John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP
  • Efficacité et tolérance de lʼassociation fixe perindopril / indapamide dans le diabète de type 2: résultats de lʼétude ADVANCE

    Journal of Hypertension Date published:
  • Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

    The Lancet Date published:
  • Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke

    Stroke Date published:
  • Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

    New England Journal of Medicine Date published:
  • Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE

    Journal of Hypertension Date published:
  • Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials

    European Heart Journal Date published:
  • Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

    BMJ Date published:
  • Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial

    The Lancet Neurology Date published:
  • An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event

    The European Journal of Health Economics Date published:
  • APOE genotype, ethnicity, and the risk of cerebral hemorrhage

    Neurology Date published:
  • Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

    Kidney International Date published:
  • Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

    New England Journal of Medicine Date published:
  • Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes

    Diabetes Care Date published:
  • ADVANCES IN REDUCING THE BURDEN OF VASCULAR DISEASE IN TYPE 2 DIABETES

    Clinical and Experimental Pharmacology and Physiology Date published:
  • INTRODUCTION

    Clinical and Experimental Pharmacology and Physiology Date published:
  • RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL

    Date published: